[1] CLARKE J, WU H C, JAYASINGHE L, et al. Continuous base identification for single-molecule nanopore DNA sequencing[J]. Nat Nanotechnol,2009,4(4):265-270.
[2] VISSERS L E, DE VRIES B B, OSOEGAWA K, et al. Array-based comparative genomic hybridization for the genomewide detection of submicroscopic chromosomal abnormalities[J]. Am J Hum Genet,2003,73(6):1261-1270.
[3] KEARNEY H M, KEARNEY J B, CONLIN L K. Diagnostic implications of excessive homozygosity detected by SNP-based microarrays:consanguinity, uniparental disomy, and recessive single-gene mutations[J]. Clin Lab Med,2011,31(4):595-613, ix.
[4] SAHOO T, DZIDIC N, STRECKER M N, et al. Comprehensive genetic analysis of pregnancy loss by chromosomal microarrays:outcomes, benefits, and challenges[J]. Genet Med,2017,19(1):83-89.
[5] DHILLON R K, HILLMAN S C, MORRIS R K, et al. Additional information from chromosomal microarray analysis (CMA) over conventional karyotyping when diagnosing chromosomal abnormalities in miscarriage:a systematic review and meta-analysis[J]. BJOG,2014,121(1):11-21.
[6] REDDY U M, PAGE G P, SAADE G R, et al. Karyotype versus microarray testing for genetic abnormalities after stillbirth[J]. N Engl J Med,2012,367(23):2185-2193.
[7] MILLER D T, ADAM M P, ARADHYA S, et al. Consensus statement:chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies[J]. Am J Hum Genet,2010,86(5):749-764.
[8] AL-MOUSA H, ABOUELHODA M, MONIES D M, et al. Unbiased targeted next-generation sequencing molecular approach for primary immunodeficiency diseases[J]. J Allergy Clin Immunol,2016,137(6):1780-1787.
[9] YOHE S, THYAGARAJAN B. Review of clinical next-generation sequencing[J]. Arch Pathol Lab Med,2017.[Epub ahead of print]
[10] FERNÁNDEZ-MARMIESSE A, GOUVEIA S, COUCE M L. NGS technologies as a turning point in rare disease research, diagnosis, and treatment[J]. Curr Med Chem,2017.[Epub ahead of print]
[11] DEAN F B, HOSONO S, FANG L, et al. Comprehensive human genome amplification using multiple displacement amplification[J]. Proc Natl Acad Sci U S A,2002,99(8):5261-5266.
[12] HANDYSIDE A H, ROBINSON M D, SIMPSON R J, et al. Isothermal whole genome amplification from single and small numbers of cells:a new era for preimplantation genetic diagnosis of inherited disease[J]. Mol Hum Reprod,2004,10(10):767-772.
[13] YE Y, YU P, YONG J, et al. Preimplantational genetic diagnosis and mutation detection in a family with duplication mutation of DMD gene[J]. Gynecol Obstet Invest,2014,78(4):272-278.
[14] XU C, XU B, HUANG H, et al. Preimplantation genetic diagnosis for X-linked agammaglobulinemia:a case report[J]. Fertil Steril,2009,91(5):1958.e5-7.
[15] TAN Y Q, TAN K, ZHANG S P, et al. Single-nucleotide polymorphism microarray-based preimplantation genetic diagnosis is likely to improve the clinical outcome for translocation carriers[J]. Hum Reprod,2013,28(9):2581-2592.
[16] FEICHTINGER M, VACCARI E, CARLI L, et al. Non-invasive preimplantation genetic screening using array comparative genomic hybridization on spent culture media:a proof-of-concept pilot study[J]. Reprod Biomed Online,2017,34(6):583-589.
[17] LO Y M, TEIN M S, LAU T K, et al. Quantitative analysis of fetal DNA in maternal plasma and serum:implications for noninvasive prenatal diagnosis[J]. Am J Hum Genet,1998,62(4):768-775.
[18] BIANCHI D W, PLATT L D, GOLDBERG J D, et al. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing[J]. Obstet Gynecol,2012,119(5):890-901.
[19] JIA Y, ZHAO H, SHI D, et al. Genetic effects of a 13q31.1 microdeletion detected by noninvasive prenatal testing (NIPT)[J]. Int J Clin Exp Pathol,2014,7(10):7003-7011.
[20] LAU T K, CHEUNG S W, LO P S, et al. Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA:review of 1982 consecutive cases in a single center[J]. Ultrasound Obstet Gynecol,2014,43(3):254-264.
[21] LV W, WEI X, GUO R, et al. Noninvasive prenatal testing for Wilson disease by use of circulating single-molecule amplification and resequencing technology (cSMART)[J]. Clin Chem,2015,61(1):172-181.
[22] MARDY A, WAPNER R J. Confined placental mosaicism and its impact on confirmation of NIPT results[J]. Am J Med Genet C Semin Med Genet,2016,172(2):118-122.
[23] HOU Y, FAN W, YAN L, et al. Genome analyses of single human oocytes[J]. Cell,2013,155(7):1492-1506.